Reduced plasmalogen concentration as a surrogate marker of oxidative stress in elderly septic patients

Archives of Gerontology and Geriatrics

Volumn 57, Issue 1, 2013, Pages 66-69

  Brosche, Thorolf ^a   Bertsch, Thomas ^b   Sieber, Cornel C ^a   Hoffmann, Ursula ^c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b KLINIKUM NÜRNBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Elderly patients; Lipid oxidation; Oxidative stress; Plasmalogens; Sepsis

Indexed keywords

ACETAL DERIVATIVE; C REACTIVE PROTEIN; CREATININE; DIMETHYL ACETAL; PHOSPHOLIPID; PLASMALOGEN; PLASMALOGEN VINYL ETHER BOND; UNCLASSIFIED DRUG;

AGED; APACHE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GAS CHROMATOGRAPHY; HUMAN; LEUKOCYTE COUNT; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SEPSIS; THROMBOCYTE COUNT;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PLASMALOGENS; SEPSIS; SURVIVAL RATE;

EID: 84876467985     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2013.02.007     Document Type: Article

References (31)

1. Behnes M., Brueckmann M., Liebe V., Liebetrau C., Lang S., Putensen C., et al. Levels of oxidized low-density lipoproteins are increased in patients with severe sepsis. Journal of Critical Care 2008, 23:537-541.
2. Berg R.M., Møller K., Bailey D.M. Neuro-oxidative-nitrosative stress in sepsis. Journal of Cerebral Blood Flow and Metabolism 2011, 31:1532-1544. (Epub 2011 April 13). 10.1038/jcbfm.2011.48.
3. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655.
4. Brites P., Waterham H.R., Wanders R.J.A. Functions and biosynthesis of plasmalogens in health and disease. Biochimica et Biophysica Acta 2004, 1636:219-231.
5. Brosche T. Plasmalogen phospholipids - facts and theses to their antioxidative qualities. Archives of Gerontology and Geriatrics 1997, 25:73-81.
6. Brosche T. Plasmalogen levels in serum from patients with impaired carbohydrate or lipid metabolism and in elderly subjects with normal metabolic values. Archives of Gerontology and Geriatrics 2001, 32:283-294.
7. Brosche T., Brueckmann M., Haase K.K., Sieber C., Bertsch T. Decreased plasmalogen concentration as a surrogate marker of oxidative stress in patients presenting with acute coronary syndromes or supraventricular tachycardias. Clinical Chemistry and Laboratory Medicine 2007, 45:689-691.
8. Brosche T., Kral C., Summa J.D., Platt D. Effective Lovastatin therapy in elderly hypercholesterolemic patients - an antioxidative impact?. Archives of Gerontology and Geriatrics 1996, 22:207-221.
9. Brosche T., Platt D., Knopf B. Decreased concentrations of serum phospholipid plasmalogens indicate oxidative burden of uraemic patients undergoing haemodialysis. Nephron 2002, 90:58-63.
10. Chuang C.C., Shiesh S.C., Chi C.H., Tu Y.F., Hor L.I., Shieh C.C., et al. Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis. Critical Care 2006, 10(1):R36.
11. Engelmann B. Plasmalogens: Targets for oxidants and major lipophilic antioxidants. Biochemical Society Transactions 2004, 32(I):147-150.
12. Farooqui A.A., Horrocks L.A. Phospholipase A2-generated lipid mediators in the brain: The good, the bad and the ugly. Neuroscientist 2006, 12:245-260.
13. Galley H.F. Oxidative stress and mitochondrial dysfunction in sepsis. British Journal of Anaesthesia 2011, 107:57-64. (Epub 2011 May 19).
14. Garrabou G., Morén C., López S., Tobías E., Cardellach F., Miró O., et al. The effects of sepsis on mitochondria. Journal of Infectious Diseases 2012, 205:392-400. (Epub 2011 December 16).
15. Ghoneim W., El-Bassyouni H.T., Abdel Maksoud S.A. Peroxisomal biogenesis disorder biomarkers. Clinica y Laboratorio 2011, 57:469-480.
16. Huet O., Dupic L., Harrois A., Duranteau J. Oxidative stress and endothelial dysfunction during sepsis. Frontiers in Bioscience 2011, 16:1986-1995.
17. Kaddurah-Daouk R., Baillie R.A., Zhu H., Zeng Z.B., Wiest M.M., Nguyen U.T., et al. Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study. Metabolomics 2010, 6(2):191-201. (Epub 2010 April 1).
18. Knaus W.A., Draper E.A., Wagner D., Zimmermann J.E. APACHE II: A severity of disease classification system. Critical Care Medicine 1985, 13:818-829.
19. Kothari N., Keshari R.S., Bogra J., Kohli M., Abbas H., Malik A., et al. Increased myeloperoxidase enzyme activity in plasma is an indicator of inflammation and onset of sepsis. Journal of Critical Care 2011, 26. 435.e1-e7.
20. Lessing J., Fuchs B. Plasmalogens in biological systems: Their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis. Current Medicinal Chemistry 2009, 16:2021-2041.
21. Maeba R., Maeba T., Kinoshita M., Takao K., Takenaka H., Kusano J., et al. Plasmalogens in human serum positively correlate with high density lipoprotein and decrease with aging. Journal of Atherosclerosis and Thrombosis 2007, 14:12-18.
22. Mishra V., Baines M., Perry S.E., McLaughlin P.J., Carson J., Wenstone R., et al. Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clinical Nutrition 2007, 26(1):41-50.
23. Mishra V., Baines M., Wenstone R., Shenkin A. Markers of oxidative damage, antioxidant status and clinical outcome in critically ill patients. Annals of Clinical Biochemistry 2005, 42:269-276.
24. Mühl D., Woth G., Drenkovics L., Varga A., Ghosh S., Csontos C., et al. Comparison of oxidative stress & leukocyte activation in patients with severe sepsis & burn injury. Indian Journal of Medical Research 2011, 134:69-78.
25. Piechota M., Barylski M., Hannam S., Piechota-Urbańska M., Banach M. Rationale of statin therapy in septic patients. Current Vascular Pharmacology 2012, (Epub ahead of print).
26. Rocha M., Herance R., Rovira S., Hernandez-Mijares A., Victor V.M. Mitochondrial dysfunction and antioxidant therapy in sepsis. Infectious Disorders Drug Targets 2012, 12:161-178.
27. Von Dessauer B., Bongain J., Molina V., Quilodrán J., Castillo R., Rodrigo R. Oxidative stress as a novel target in pediatric sepsis management. Journal of Critical Care 2011, 26(1):103.e1-103.e7.
28. Wallner S., Schmitz G. Plasmalogens the neglected regulatory and scavenging lipid species. Chemistry and Physics of Lipids 2011, 164:573-589.
29. Ware L.B., Fessel J.P., May A.K., Roberts L.J. Plasma biomarkers of oxidant stress and development of organ failure in severe sepsis. Shock 2011, 36(1):12-17.
30. Zoeller R.A., Lake A.C., Nagan N., Gaposchkin D.P., Legner M.A., Lieberthal W. Plasmalogens as endogenous antioxidants: Somatic cell mutants reveal the importance of the vinyl ether. Biochemical Journal 1999, 338:769-776.
31. Zoeller R.A., Morand O.H., Raetz C.H.R. A possible role for plasmalogens in protecting animal cells against photosensitized killing. Journal of Biological Chemistry 1988, 263:11590-11596.